Today: 11 June 2026
Browse Category

NASDAQ:LRCX 20 December 2025 - 29 December 2025

Lam Research near $180 as year-end positioning puts chip-tool stocks back in play

Lam Research near $180 as year-end positioning puts chip-tool stocks back in play

Lam Research closed up 0.4% at $178.07 Friday in thin post-holiday trading. Investors await December-quarter results after the quarter ended Sunday, with guidance set at $5.20 billion revenue plus or minus $300 million. Fed minutes due Tuesday and light volumes could drive volatility. Other chip-equipment stocks also edged higher.
Lam Research stock steadies near $180 as investors eye Fed minutes and January earnings

Lam Research stock steadies near $180 as investors eye Fed minutes and January earnings

Lam Research shares closed at $178.07, up 0.4% in the latest session, outpacing broader indexes. Analysts cited in recent broker notes and reports expect a rebound in memory chip equipment spending in 2026. Investors are watching Fed minutes and economic data for rate signals ahead of Lam’s January earnings. The company’s fiscal quarter ended Sunday.
Lam Research Stock (LRCX) Holds Near Record Highs Into New Year’s Week: Latest Headlines, Analyst Targets, and What to Watch Monday

Lam Research Stock (LRCX) Holds Near Record Highs Into New Year’s Week: Latest Headlines, Analyst Targets, and What to Watch Monday

Lam Research shares closed Friday at $178.07, near record highs, after a strong late-December rally. After-hours trading showed a slight uptick to $178.19. Recent analyst reports highlighted demand for AI infrastructure and advanced packaging, while several firms raised price targets toward $200. U.S. markets will reopen Monday for a holiday-shortened week.
28 December 2025
Lam Research Stock (LRCX) Climbs to Record Close as AI-Driven Chip Equipment Cycle Stays in Focus—What Investors Should Watch Before Monday

Lam Research Stock (LRCX) Climbs to Record Close as AI-Driven Chip Equipment Cycle Stays in Focus—What Investors Should Watch Before Monday

Lam Research closed Friday at $178.07, up 0.4% and near its 52-week high of $179.80, as trading volume remained light after Christmas. Major U.S. indexes ended nearly flat, with the Dow, S&P 500, and Nasdaq posting small declines but holding weekly gains. Semiconductor ETFs were mixed. Lam’s recent surge comes amid increased AI infrastructure spending and a rebound in memory demand.
27 December 2025
Lam Research Stock (LRCX) Near Record Highs After Analyst Target Hikes as AI Chip Equipment Forecasts Brighten Ahead of Monday’s Open

Lam Research Stock (LRCX) Near Record Highs After Analyst Target Hikes as AI Chip Equipment Forecasts Brighten Ahead of Monday’s Open

Lam Research shares closed near record highs at $178.07 late Friday in New York, after hitting $179.77 intraday. The company’s market cap stands at about $162.4 billion, trading at 28 times earnings. Trading was subdued post-Christmas, with major U.S. indexes finishing slightly lower on light volume. SEMI forecasts chip equipment spending to rise into 2026 and 2027, fueled by AI-related demand.
Lam Research (LRCX) Stock Today: Why Shares Are Near Record Highs, Fresh Analyst Targets, and What Investors Should Watch Next

Lam Research (LRCX) Stock Today: Why Shares Are Near Record Highs, Fresh Analyst Targets, and What Investors Should Watch Next

Lam Research traded near $178.70 Friday afternoon in New York, holding close to record highs amid thin post-holiday volume. Investors continue to price in strong AI-driven demand for semiconductor equipment, with memory spending seen as a key driver. Peers KLA and Applied Materials also edged higher, while Micron slipped. Lam’s latest quarter showed $5.32 billion revenue and a 50.6% non-GAAP gross margin.
26 December 2025
Lam Research (LRCX) Stock: Key News, Analyst Forecasts, and Risks to Watch Before the Market Opens on Dec. 26, 2025

Lam Research (LRCX) Stock: Key News, Analyst Forecasts, and Risks to Watch Before the Market Opens on Dec. 26, 2025

Lam Research closed at $177.33 on Dec. 24 ahead of the Dec. 26 market open, with after-hours trading showing a slight uptick. The company reported $5.32 billion in revenue and $1.24 GAAP EPS last quarter. Management forecasts $5.20 billion ± $300 million in revenue for the current quarter. Headlines this week include CEO share sales and analyst price target increases.
26 December 2025
Semiconductor Stocks Today (Dec 25, 2025): Nvidia–Groq Deal, Micron’s HBM Boom, Intel Foundry Questions, and 2026 Forecasts

Semiconductor Stocks Today (Dec 25, 2025): Nvidia–Groq Deal, Micron’s HBM Boom, Intel Foundry Questions, and 2026 Forecasts

Nvidia signed a non-exclusive inference licensing deal with Groq, hiring its founder and president as Groq names a new CEO. Intel’s foundry business faces scrutiny after Nvidia halted evaluation of its 18A process. Micron raised its 2026 capex forecast, citing tight AI memory supply. Equipment spending projections rose again as investors track U.S.–China policy risks and possible Nvidia shipments to China.
Lam Research (LRCX) Stock News Today: Record Highs, CEO Share Sale, Analyst Price Targets, and 2026 Outlook (Dec. 25, 2025)

Lam Research (LRCX) Stock News Today: Record Highs, CEO Share Sale, Analyst Price Targets, and 2026 Outlook (Dec. 25, 2025)

Lam Research shares closed at a 52-week high of $177.33 in a shortened Christmas Eve session, with trading volume well below average. CEO Tim Archer sold 163,300 shares on December 17 under a pre-arranged 10b5-1 plan, according to a Form 4 filing. The stock’s rally follows strong AI-driven demand for memory equipment. U.S. markets are closed December 25.
25 December 2025
Lam Research (LRCX) Stock News on Dec. 24, 2025: CEO Share Sale, Analyst Targets, and the AI-Driven Wafer-Fab Equipment Outlook

Lam Research (LRCX) Stock News on Dec. 24, 2025: CEO Share Sale, Analyst Targets, and the AI-Driven Wafer-Fab Equipment Outlook

Lam Research traded near $177 in midday Dec. 24, approaching record highs after CEO Timothy Archer disclosed the sale of 163,300 shares for about $26.8 million under a 10b5-1 plan. The stock is up from its Dec. 23 close of $175.16. Trading volume was lighter ahead of the 1 p.m. ET early market close for Christmas Eve.
Lam Research (LRCX) Stock After Hours on Dec. 23, 2025: UBS Lifts Target to $200—What to Know Before the Dec. 24 Market Open

Lam Research (LRCX) Stock After Hours on Dec. 23, 2025: UBS Lifts Target to $200—What to Know Before the Dec. 24 Market Open

Lam Research closed Tuesday at $175.16, down 0.06%, then rose to $175.73 in after-hours trading. The stock traded near its 52-week high of $177.29 on volume of 6.4 million shares. UBS raised its price target to $200, citing strength in AI and advanced memory demand. Other firms also lifted targets, while some analysts flagged valuation risks.
24 December 2025
Lam Research (LRCX) Stock After the Bell on Dec. 22, 2025: New High, Fresh Analyst Targets, and What to Watch Before Tuesday’s Open

Lam Research (LRCX) Stock After the Bell on Dec. 22, 2025: New High, Fresh Analyst Targets, and What to Watch Before Tuesday’s Open

Lam Research shares closed at $175.26 on Monday, up 1.74%, hitting a new 52-week high of $175.96. Volume reached about 10.9 million shares, slightly below average. After-hours trading saw modest gains, with quotes ranging from $175.92 to $176.33. The move followed strength in semiconductor stocks and a positive session for U.S. equities.
Lam Research (LRCX) Stock After Hours on Dec. 22, 2025: New 52-Week High, Analyst Target Hikes, and What to Watch Before Tuesday’s Open

Lam Research (LRCX) Stock After Hours on Dec. 22, 2025: New 52-Week High, Analyst Target Hikes, and What to Watch Before Tuesday’s Open

Lam Research closed at a record $175.26 on Dec. 22, then edged up to $175.40 after hours. The stock set a new 52-week high of $175.96 during the session, outperforming peers as U.S. equities rose. Trading volume was slightly below average. Lam’s gains followed strong results from Micron and broad semiconductor strength.
Lam Research Stock (LRCX) News Today: Shares Hit Fresh Highs as AI Chip Spending Lifts Forecasts Into 2026

Lam Research Stock (LRCX) News Today: Shares Hit Fresh Highs as AI Chip Spending Lifts Forecasts Into 2026

Lam Research shares surged 4.6% to $172.27 on Monday, reaching a new 52-week high of $173.58 last Friday amid heavy trading. The stock is up 138.5% year-to-date, fueled by strong AI-driven demand for semiconductor equipment and multiple price target hikes. Wall Street is watching for Lam’s next earnings, with consensus expecting $1.15 per share, up 26.4% from last year.
AI Stocks Today (Dec. 22, 2025): Nvidia’s China Chip Pivot, Micron’s Memory Squeeze, and 2026 Forecasts Driving the AI Trade

AI Stocks Today (Dec. 22, 2025): Nvidia’s China Chip Pivot, Micron’s Memory Squeeze, and 2026 Forecasts Driving the AI Trade

Nvidia plans to begin shipping H200 AI chips to China by mid-February, pending Beijing approval, after the U.S. reversed restrictions and imposed a 25% fee. AI chip stocks led U.S. markets higher Monday morning, with Nvidia up 1.37% and Micron up 2.18%. Broader tech indexes also rose. Trading volume is expected to be lighter ahead of the Christmas holiday.
Lam Research (LRCX) Stock: Key News, Analyst Forecasts, and What to Watch Before the Dec. 22, 2025 Market Open

Lam Research (LRCX) Stock: Key News, Analyst Forecasts, and What to Watch Before the Dec. 22, 2025 Market Open

Lam Research shares closed at $172.27 after hitting new highs last week, driven by analyst price-target hikes and optimism over AI-related semiconductor spending. Trading volume surged above normal levels. Wall Street firms, including Oppenheimer and Mizuho, raised targets to $200. U.S. markets face lighter liquidity this holiday-shortened week, increasing the potential for sharp price swings.
22 December 2025
Lam Research Stock Week Ahead (LRCX): Analysts Lift Targets as AI Chip Spending Outlook Brightens Into a Holiday-Shortened Market

Lam Research Stock Week Ahead (LRCX): Analysts Lift Targets as AI Chip Spending Outlook Brightens Into a Holiday-Shortened Market

Lam Research shares closed Friday at $172.27, up 4.57%, near a record high after analysts raised price targets to as much as $200. The stock’s rally tracks strong AI-driven demand signals and optimism for 2026 capital spending. Trading volume may be thin in the holiday-shortened week, increasing volatility.
Lam Research (LRCX) Stock News Today: Record High, Analyst Upgrades to $200, and 2026 Outlook (Dec. 20, 2025)

Lam Research (LRCX) Stock News Today: Record High, Analyst Upgrades to $200, and 2026 Outlook (Dec. 20, 2025)

Lam Research shares jumped 4.6% to $172.27 on Dec. 19, hitting a new high after a series of analyst upgrades and price-target increases tied to AI and memory chip demand. Deutsche Bank and B. Riley raised targets to $195, while Mizuho and Oppenheimer set targets at $200. Trading volume surged to 38.47 million shares. Markets were closed on Dec. 20.
20 December 2025
1 5 6 7 8 9 10

Stock Market Today

  • What is an IPO as SpaceX Prepares for U.S. Stock Market Debut
    June 10, 2026, 6:01 PM EDT. An IPO, or Initial Public Offering, is when a private company sells shares to the public for the first time, becoming publicly traded. SpaceX, the aerospace manufacturer, is expected to make its debut on the U.S. stock market, marking one of the most anticipated IPOs in recent years. This move allows retail and institutional investors to buy equity in SpaceX, potentially impacting the space industry and tech sectors. The IPO process involves regulatory filings, pricing, and public trading, providing companies with capital for expansion. SpaceX's offering could reshape market dynamics, drawing significant investor interest given its innovations and growth trajectory.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Go toTop